An interventional study of Electroacupuncture and Standard Multimodal Analgesia in Postoperative Pain, Urinary Retention and Hemorrhoids, sponsored by University of Medicine and Pharmacy at Ho Chi Minh City. Completed at 1 site in Vietnam. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-13.
Sponsored by University of Medicine and Pharmacy at Ho Chi Minh City · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Pain, Postoperative with a site in Vietnam — 3 open to participants now, 3 under way, none of them phase 3. Pain, Postoperative · Vietnam.
Among the 15 studies in Pain, Postoperative with a site in Vietnam, this one is the 13th largest by enrollment, is one of 4 that started in 2026, is one of 12 with no phase, and was the 15th registered.
5,654 studies on the registry are indexed under Pain, Postoperative; 1,233 are open to participants now.
Browse Pain, Postoperative studies →3 of the 15 studies in Pain, Postoperative with a site in Vietnam are open now. Recruiting first, the newest first:
University of Medicine and Pharmacy at Ho Chi Minh City · Sites in Vietnam
Ages 3–6
Vinmec Healthcare System · Sites in Vietnam
Ages 18–65 · Women only
University Medical Center Ho Chi Minh City (UMC) · Sites in Vietnam
Ages 18+ · Women only
A study can be open while its sites in Vietnam have not opened yet or have stopped. Only those recruiting at a site in Vietnam →
Of the 676 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 327 (48%) stop at 75 or younger; 74 take children under 18; 128 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 1 · Phase 3 2 · Phase 4 1
First in 2016; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 35 is below the median of 75 across 4,835 interventional studies indexed under Pain, Postoperative.
Median enrollment 60 across the 15 interventional studies. Of the 12 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 15 has an industry lead sponsor. The 8 most frequent:
University of Medicine and Pharmacy at Ho Chi Minh City is the lead sponsor of 128 studies on the registry; 44 are open to participants now.
University of Medicine and Pharmacy at Ho Chi Minh City has 6 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
1 of the studies in Pain, Postoperative with a site in Vietnam that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07615595University Medical Center Ho Chi Minh City (UMC)Dexamethasone to Prevent Side Effects of Spinal Anesthesia in Cesarean Delivery | 2027-07-31 |
Add it to your calendar (.ics) → With an account.
Among the 15 studies in Pain, Postoperative with a site in Vietnam, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Postoperative pain and postoperative urinary retention (POUR) are common early complications following anorectal surgeries, including hemorrhoidectomy and anal fistula surgery. Standard multimodal analgesia often involves systemic opioids and non-opioid medications, which may carry side effects such as nausea, dizziness, or exacerbated urinary retention.
This prospective, non-randomized pilot study aims to evaluate the preliminary efficacy and feasibility of early neuroanatomically-guided electroacupuncture targeting the sacral plexus (pudendal nerve territory) as an adjunct to standard multimodal analgesia. Participants undergoing anorectal surgical procedures are allocated by preference to receive either adjunctive electroacupuncture combined with standard analgesic care or standard analgesic care alone.
Pain intensity assessed via the Visual Analogue Scale (VAS) at 8, 12, and 24 hours post-surgery, along with the incidence of postoperative urinary retention and needling-related adverse events, are assessed to evaluate whether early electroacupuncture enhances acute recovery and supports the design of a larger randomized controlled trial.
BACKGROUND \& RATIONALE:
Acute post-surgical pain following hemorrhoidectomy (Milligan-Morgan, stapled hemorrhoidopexy) and fistulotomy remains intense due to dense somatic innervation of the perineum. Additionally, reflex spasm of the internal anal sphincter and detrusor inhibition frequently contribute to urinary retention. Traditional medicine sacral acupoints (Baliao) anatomically correlate with sacral foramina (S2-S4) giving rise to the pudendal and pelvic splanchnic nerves. Early targeted neurostimulation may modulate pudendal afferents, restore autonomic balance, and alleviate pain without systemic adverse events.
STUDY PROTOCOL \& INTERVENTIONS:
Adult patients scheduled for anorectal surgery are enrolled and allocated based on informed preference into two parallel groups:
OUTCOME EVALUATION:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Bilateral BL32 (Ciliao) and BL34 (Xialiao) needled within 3-4 hours postoperatively; stimulated with dense-disperse wave 2-100 Hz for 20 minutes at individualized sensory threshold; needles retained, and a second 20-minute stimulation delivered at 12 hours, combined with standard postoperative analgesia (IV paracetamol + IM NSAIDs)
Procedure: Electroacupuncture
Routine post-surgical analgesic care anchored on IV Paracetamol and IM NSAIDs (plus rescue opioids/add-on medications as clinically indicated) without acupuncture intervention.
Other: Standard Multimodal Analgesia
Bilateral electroacupuncture delivered at sacral acupoints BL32 (Ciliao) and BL34 (Xialiao), initiated within 3-4 hours postoperatively. Stimulation is administered using a dense-disperse wave at 2-100 Hz for 20 minutes at an individualized sensory-threshold intensity. Needles are retained in situ, and a second 20-minute electroacupuncture session is delivered at 12 hours post-surgery via the retained needles.
Standard postoperative multimodal analgesia protocol consisting of intravenous Paracetamol and intramuscular NSAIDs, with supplementary rescue analgesics (e.g., fentanyl, tramadol, nefopam) administered as clinically indicated.
Postoperative Pain Intensity (VAS score at 24 hours)
Visual Analogue Scale ranging from 0 (no pain) to 10 (worst imaginable pain).
Time frame: 24 hours postoperatively
Urinary retention
Incidence of Postoperative Urinary Retention (POUR)
Time frame: 24 hours postoperatively
Feasibility and Patient Tolerance of Early Retained Electroacupuncture
Feasibility assessed by the protocol completion rate (successful delivery of both 20-minute electroacupuncture sessions at 3-4 hours and 12 hours without premature needle dislodgement or early termination due to intolerable discomfort) and patient-reported complaints regarding discomfort or irritation associated with the 12-hour needle retention protocol. 1\. pilot trĩ -báo.docx
Time frame: Up to 24 hours postoperatively
Plan to share: Yes — De-identified individual participant data collected during the trial will be available upon reasonable request from qualified researchers after publication of the primary study results. Requests should be directed to the corresponding author (vtlna@ump.edu.vn) and will require a formal methodologically sound proposal and a data transfer agreement approved by the institutional ethics committee.
Supporting information: Study protocol, Statistical analysis plan, Analytic code
Time frame: The de-identified individual participant data and supporting documents will be available starting 6 months after the official publication of the primary study results and will remain accessible for up to 3 years.
Access criteria: Data will be made available to qualified researchers and clinicians who submit a methodologically sound research proposal for secondary analysis or meta-analysis. Requests must be directed to the corresponding author (vtlna@ump.edu.vn). Access requires review and approval from the study investigators and completion of a signed data use agreement.
Ran from Jul 2026 to primary completion in Sep 2026, 2 months.
Of 2,097 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 2 months is below that.
Counting every sponsor, half of 2,110 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Medicine and Pharmacy at Ho Chi Minh City →